CLINUVEL's CSO, Dr Hank Agersborg, on the final year of drug filing
CLINUVEL's ASX announcement on the SU results can be found here.
Read the CEO's Technical note on the Phase II results here.
This audio file is available for download in mp3 format. Right click here and select "Save target as" to save this file to your computer.